Medikit Co.,Ltd. (TYO:7749)
Japan
· Delayed Price · Currency is JPY 2,662.00
+86.00 (3.34%)
Mar 10, 2025, 3:30 PM JST
Medikit Income Statement
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2019 - 2015 |
| Revenue | 22,332 | 21,850 | 21,607 | 20,130 | 19,312 | 19,893 | Upgrade
|
| Revenue Growth (YoY) | 1.42% | 1.12% | 7.34% | 4.24% | -2.92% | 7.52% | Upgrade
|
| Cost of Revenue | 13,655 | 13,098 | 13,289 | 11,949 | 11,720 | 11,572 | Upgrade
|
| Gross Profit | 8,677 | 8,752 | 8,318 | 8,181 | 7,592 | 8,321 | Upgrade
|
| Selling, General & Admin | 3,741 | 3,747 | 3,932 | 3,527 | 3,590 | 3,761 | Upgrade
|
| Operating Expenses | 4,070 | 4,077 | 4,204 | 3,762 | 3,817 | 3,997 | Upgrade
|
| Operating Income | 4,607 | 4,675 | 4,114 | 4,419 | 3,775 | 4,324 | Upgrade
|
| Interest Expense | -7 | -7 | -7 | -7 | -7 | -7 | Upgrade
|
| Interest & Investment Income | 24 | 19 | 18 | 40 | 19 | 23 | Upgrade
|
| Currency Exchange Gain (Loss) | -23 | -10 | -28 | -3 | - | -18 | Upgrade
|
| Other Non Operating Income (Expenses) | 44 | 84 | 63 | 84 | 69 | 45 | Upgrade
|
| EBT Excluding Unusual Items | 4,645 | 4,761 | 4,160 | 4,533 | 3,856 | 4,367 | Upgrade
|
| Gain (Loss) on Sale of Investments | -4 | -4 | 124 | -50 | 58 | - | Upgrade
|
| Gain (Loss) on Sale of Assets | 21 | 19 | 21 | -5 | 15 | 14 | Upgrade
|
| Asset Writedown | - | -1 | -15 | -5 | -1 | -48 | Upgrade
|
| Other Unusual Items | -1 | -1 | - | -1 | - | - | Upgrade
|
| Pretax Income | 4,661 | 4,774 | 4,290 | 4,472 | 3,928 | 4,333 | Upgrade
|
| Income Tax Expense | 1,568 | 1,705 | 1,426 | 1,479 | 1,269 | 1,446 | Upgrade
|
| Net Income | 3,093 | 3,069 | 2,864 | 2,993 | 2,659 | 2,887 | Upgrade
|
| Net Income to Common | 3,093 | 3,069 | 2,864 | 2,993 | 2,659 | 2,887 | Upgrade
|
| Net Income Growth | 7.88% | 7.16% | -4.31% | 12.56% | -7.90% | 12.07% | Upgrade
|
| Shares Outstanding (Basic) | 15 | 16 | 17 | 17 | 17 | 17 | Upgrade
|
| Shares Outstanding (Diluted) | 15 | 16 | 17 | 17 | 17 | 17 | Upgrade
|
| Shares Change (YoY) | -11.79% | -2.70% | -0.10% | -0.57% | -0.34% | 0.01% | Upgrade
|
| EPS (Basic) | 208.82 | 187.92 | 170.64 | 178.14 | 157.37 | 170.27 | Upgrade
|
| EPS (Diluted) | 208.82 | 187.92 | 170.64 | 178.14 | 157.37 | 170.27 | Upgrade
|
| EPS Growth | 22.30% | 10.13% | -4.21% | 13.20% | -7.58% | 12.07% | Upgrade
|
| Free Cash Flow | - | 3,146 | 3,497 | 1,374 | 2,093 | 2,095 | Upgrade
|
| Free Cash Flow Per Share | - | 192.64 | 208.35 | 81.78 | 123.87 | 123.56 | Upgrade
|
| Dividend Per Share | 90.000 | 80.000 | 70.000 | 60.000 | 50.000 | 50.000 | Upgrade
|
| Dividend Growth | 20.00% | 14.29% | 16.67% | 20.00% | 0% | 11.11% | Upgrade
|
| Gross Margin | 38.85% | 40.05% | 38.50% | 40.64% | 39.31% | 41.83% | Upgrade
|
| Operating Margin | 20.63% | 21.40% | 19.04% | 21.95% | 19.55% | 21.74% | Upgrade
|
| Profit Margin | 13.85% | 14.05% | 13.25% | 14.87% | 13.77% | 14.51% | Upgrade
|
| Free Cash Flow Margin | - | 14.40% | 16.18% | 6.83% | 10.84% | 10.53% | Upgrade
|
| EBITDA | 6,317 | 6,219 | 5,437 | 5,688 | 5,083 | 5,642 | Upgrade
|
| EBITDA Margin | 28.29% | 28.46% | 25.16% | 28.26% | 26.32% | 28.36% | Upgrade
|
| D&A For EBITDA | 1,710 | 1,544 | 1,323 | 1,269 | 1,308 | 1,318 | Upgrade
|
| EBIT | 4,607 | 4,675 | 4,114 | 4,419 | 3,775 | 4,324 | Upgrade
|
| EBIT Margin | 20.63% | 21.40% | 19.04% | 21.95% | 19.55% | 21.74% | Upgrade
|
| Effective Tax Rate | 33.64% | 35.71% | 33.24% | 33.07% | 32.31% | 33.37% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.